Loading article…
Morgan Stanley disclosed modest holdings in two XRP ETFs, highlighting growing institutional interest but no direct spot XRP investment.
Morgan Stanley, managing roughly $7.4 trillion in assets, recently revealed exposure to XRP through two exchange‑traded funds, a move that underscores rising institutional interest in the cryptocurrency despite the firm’s continued avoidance of a direct spot XRP ETF [3].
Key takeaways
Morgan Stanley’s filing, made public in its Q1 2026 Form 13F, shows the firm owns a modest amount of XRP‑related securities. The bank reported 1,700 shares of the Volatility Shares XRP ETF (ticker XRPI), valued at approximately $12,886, and 100 shares of the Grayscale XRP Trust ETF (ticker GXRP), valued at about $2,100, bringing the total exposure to roughly $15,000 [4]. While the dollar amount is tiny relative to the firm’s $7.4 trillion in assets under management, the disclosure signals that large U.S. financial institutions are beginning to allocate capital to XRP‑linked products.
The move arrives amid a broader institutional trend. Spot XRP ETFs, which launched in November 2025, have accumulated $1.53 billion in cumulative inflows, and the overall XRP ETF category recorded a net inflow of $256 million in 2026 [1][4]. Yet, Morgan Stanley has not taken a position in any spot XRP ETF, a product that would provide direct exposure to the token itself rather than through a fund structure. This mirrors the cautious stance of many banks that prefer regulated ETF vehicles over direct cryptocurrency holdings.
Morgan Stanley’s decision contrasts sharply with Goldman Sachs, which fully exited its XRP ETF positions in the same quarter [4]. While Goldman Sachs withdrew, Morgan Stanley entered the space, albeit with a very small allocation. The differing approaches highlight a split among major financial firms regarding how to engage with XRP. Some, like Goldman Sachs, have retreated from XRP exposure, whereas others are testing the waters through regulated ETF products, reflecting a nuanced view of risk and regulatory clarity.
The broader market context adds depth to these moves. Ripple’s ongoing regulatory progress—including a settlement with the and classification as a digital commodity by both the SEC and CFTC—has helped pave the way for institutional products, but price performance remains muted, with XRP trading around $1.34, far below its 2025 peak of $3.65 [1]. Institutional investors appear to be betting on the potential for future adoption rather than current price momentum.
Coverage is mostly measured — 120 of 168 reports stay neutral.
Every Monday — the token unlocks, Fed dates & catalysts set to move crypto and markets this week. So you’re never blindsided.
Free · 3-min read · one-click unsubscribe
Most institutional transactions on the ledger use Ripple's stablecoin, RLUSD, for settlement, while XRP is only used to pay minimal network fees.
The kit provides tools for third parties to build agentic payments, aiming to automate cross-border payment workflows using AI agents.
Distributed assets are held and moved by investors in their own wallets, while represented assets are recorded on the ledger but managed elsewhere.
Morgan Stanley’s modest XRP ETF holdings illustrate a growing, albeit cautious, institutional appetite for cryptocurrency exposure through regulated vehicles. The firm’s avoidance of a spot XRP ETF suggests lingering concerns about direct token ownership, regulatory risk, or market volatility. As legislative efforts like the CLARITY Act progress, which could cement XRP’s commodity status, more banks may reassess their positions. For now, the disclosure adds to the narrative that institutional interest in XRP is rising, even as the token’s price and broader adoption remain uncertain.
AI-assisted synthesis by the TrendWatcher Editorial Desk · sourced from 4 outlets · Jun 4, 2026 · How we report
The activation of a native lending protocol and the potential for tokenized assets to trade directly on the ledger could create new utility for XRP.